KM
Kalos Management Portfolio holdings
AUM
$46.6M
1-Year Return
11.52%
This Quarter Return
+1.93%
1 Year Return
+11.52%
3 Year Return
+47.83%
5 Year Return
+70.92%
10 Year Return
–
AUM
$354M
AUM Growth
+$107M
(+43%)
Cap. Flow
+$91.5M
Cap. Flow
% of AUM
25.86%
Top 10 Holdings %
Top 10 Hldgs %
35.1%
Holding
337
New
70
Increased
96
Reduced
119
Closed
45
Top Buys
| 1 |
BILL Holdings
BILL
|
$19.9M |
| 2 |
FS KKR Capital
FSK
|
$10.9M |
| 3 |
Invesco QQQ Trust
QQQ
|
$5.63M |
| 4 |
CION Investment
CION
|
$3.74M |
| 5 |
Apple
AAPL
|
$2.25M |
Top Sells
| 1 |
iShares Global Tech ETF
IXN
|
$5.39M |
| 2 |
NVIDIA
NVDA
|
$2.8M |
| 3 |
iShares US Basic Materials ETF
IYM
|
$2.46M |
| 4 |
Takeda Pharmaceutical
TAK
|
$2.09M |
| 5 |
iShares S&P Small-Cap 600 Growth ETF
IJT
|
$1.54M |
Sector Composition
| 1 | Technology | 14.99% |
| 2 | Financials | 11.56% |
| 3 | Healthcare | 5.03% |
| 4 | Communication Services | 5.03% |
| 5 | Consumer Discretionary | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Nucor
NUE
$33.8B
| $362K | 0.1% |
3,165
+271
| +9% | +$31K |
|
177
Visa
V
$666B
| $360K | 0.1% |
1,634
-209
| -11% | -$46K |
|
|
OXLC
178
Oxford Lane Capital
OXLC
$1.75B
| $354K | 0.1% |
43,208
+28,760
| +199% | +$236K |
|
179
Spire
SR
$4.46B
| $354K | 0.1% |
+5,779
| New | +$354K |
|
180
Sherwin-Williams
SHW
$92.9B
| $351K | 0.1% |
+1,095
| New | +$351K |
|
181
Nike
NKE
$109B
| $345K | 0.1% |
2,055
-338
| -14% | -$56.7K |
|
182
iShares MSCI Germany ETF
EWG
$2.51B
| $344K | 0.1% |
10,002
-270
| -3% | -$9.29K |
|
183
Vanguard Growth ETF
VUG
$186B
| $343K | 0.1% |
1,102
-792
| -42% | -$247K |
|
184
Origin Materials
ORGN
$77.7M
| $341K | 0.1% |
47,963
+27,125
| +130% | +$193K |
|
185
Main Street Capital
MAIN
$5.95B
| $340K | 0.1% |
7,449
+14
| +0.2% | +$639 |
|
186
Invesco S&P 500 Low Volatility ETF
SPLV
$7.99B
| $340K | 0.1% |
+5,329
| New | +$340K |
|
187
Ventas
VTR
$30.9B
| $338K | 0.1% |
6,473
-2,360
| -27% | -$123K |
|
188
InvenTrust Properties
IVT
$2.33B
| $336K | 0.1% |
+13,708
| New | +$336K |
|
189
KKR & Co
KKR
$121B
| $335K | 0.09% |
+4,250
| New | +$335K |
|
|
PARA
190
DELISTED
Paramount Global Class B
PARA
| $335K | 0.09% |
9,350
+972
| +12% | +$34.8K |
|
|
FSKR
191
DELISTED
FS KKR Capital Corp. II
FSKR
| $334K | 0.09% |
13,566
| – | – |
|
192
CoStar Group
CSGP
$37.9B
| $332K | 0.09% |
4,000
-470
| -11% | -$39K |
|
193
Procter & Gamble
PG
$375B
| $332K | 0.09% |
+2,312
| New | +$332K |
|
194
Pinnacle Financial Partners
PNFP
$7.55B
| $329K | 0.09% |
3,339
| – | – |
|
195
Netflix
NFLX
$529B
| $325K | 0.09% |
501
-20
| -4% | -$13K |
|
196
ARK Innovation ETF
ARKK
$7.49B
| $322K | 0.09% |
2,628
+267
| +11% | +$32.7K |
|
197
Acadia Pharmaceuticals
ACAD
$4.26B
| $321K | 0.09% |
18,575
-100
| -0.5% | -$1.73K |
|
198
BioCryst Pharmaceuticals
BCRX
$1.74B
| $318K | 0.09% |
23,700
-350
| -1% | -$4.7K |
|
199
SPDR MSCI USA StrategicFactors ETF
QUS
$1.56B
| $318K | 0.09% |
2,489
+24
| +1% | +$3.07K |
|
200
Ares Capital
ARCC
$15.8B
| $315K | 0.09% |
15,007
+1,219
| +9% | +$25.6K |
|